The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis
Journal of Cardiovascular Pharmacology and Therapeutics · 2024-01 · 29
DOI: 10.1177/10742484241248046 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Pharmacology and Therapeutics, online erschienen am 24.04.2024. Verfasst von Xin Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China. Hauptthemen laut MEDLINE: Atherosclerosis, Signal Transduction, STAT Transcription Factors, Janus Kinases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China.
- Hospital of Shandong University of Traditional Chinese Medicine, Jinan City, Shandong Province, China.
ORCID-Profile: Fengxia Zhang
Zitieren
APA
Zhang, X., Chen, S., Yin, G., Liang, P., Feng, Y., Yu, W., Meng, D., Liu, H., & Zhang, F. (2024). The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis. Journal of Cardiovascular Pharmacology and Therapeutics, 29. https://doi.org/10.1177/10742484241248046
Vancouver
Zhang X, Chen S, Yin G, Liang P, Feng Y, Yu W, et al. The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis. Journal of Cardiovascular Pharmacology and Therapeutics. 2024;29. doi:10.1177/10742484241248046
BibTeX
@article{Zhang2024,
author = {Zhang, Xin and Chen, Suwen and Yin, Guoliang and Liang, Pengpeng and Feng, Yanan and Yu, Wenfei and Meng, Decheng and Liu, Hongshuai and Zhang, Fengxia},
title = {The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis},
journal = {Journal of Cardiovascular Pharmacology and Therapeutics},
year = {2024},
volume = {29},
doi = {10.1177/10742484241248046}
}
EUVIMED